SEC Form 4 · accession 0002048588-26-000009
Beta Bionics, Inc. · BBNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Stephen Feider
Officer — Chief Financial Officer
Period of report
Jun 26, 2026
Accepted (ET)
Jun 30, 2026 · 4:46 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001674632
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 26, 2026 | M | 4,982 | $5.10 | A | 171,035 | D | |
| Common StockF2 | Jun 26, 2026 | S | 5,104 | $17.0467 | D | 165,931 | D | |
| Common Stock | Jun 29, 2026 | M | 4,896 | $5.10 | A | 170,827 | D | |
| Common StockF3 | Jun 29, 2026 | S | 4,896 | $17.0304 | D | 165,931 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $5.10 | Jun 26, 2026 | M | 4,982 | D | — | Sep 13, 2033 | Common Stock | 4,982 | 44,713 | D |
| Employee Stock Option (right to buy)F4 | $5.10 | Jun 29, 2026 | M | 4,896 | D | — | Sep 13, 2033 | Common Stock | 4,896 | 39,817 | D |
Explanation of responses
- F1Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
- F2The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- F3The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- F4The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.